PL1611150T3 - Sposób otrzymywania krystalicznego cyklezonidu o określonym rozmiarze cząstek - Google Patents

Sposób otrzymywania krystalicznego cyklezonidu o określonym rozmiarze cząstek

Info

Publication number
PL1611150T3
PL1611150T3 PL04723609T PL04723609T PL1611150T3 PL 1611150 T3 PL1611150 T3 PL 1611150T3 PL 04723609 T PL04723609 T PL 04723609T PL 04723609 T PL04723609 T PL 04723609T PL 1611150 T3 PL1611150 T3 PL 1611150T3
Authority
PL
Poland
Prior art keywords
particle size
preparing crystalline
defined particle
crystalline ciclesonide
ciclesonide
Prior art date
Application number
PL04723609T
Other languages
English (en)
Inventor
Beate Schmidt
Klaus Eistetter
Stefan Kaupp
Ernst Sturm
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33099298&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1611150(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PL1611150T3 publication Critical patent/PL1611150T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F21/00Dissolving

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL04723609T 2003-03-27 2004-03-26 Sposób otrzymywania krystalicznego cyklezonidu o określonym rozmiarze cząstek PL1611150T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10314097 2003-03-27
EP03007007 2003-03-27
EP04723609A EP1611150B1 (en) 2003-03-27 2004-03-26 Process for preparing crystalline ciclesonide with defined particle size
PCT/EP2004/050373 WO2004085460A1 (en) 2003-03-27 2004-03-26 Process for preparing crystalline ciclesonide with defined particle size

Publications (1)

Publication Number Publication Date
PL1611150T3 true PL1611150T3 (pl) 2012-07-31

Family

ID=33099298

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04723609T PL1611150T3 (pl) 2003-03-27 2004-03-26 Sposób otrzymywania krystalicznego cyklezonidu o określonym rozmiarze cząstek

Country Status (27)

Country Link
US (1) US9422327B2 (pl)
EP (1) EP1611150B1 (pl)
JP (1) JP4746535B2 (pl)
KR (1) KR101102709B1 (pl)
AR (1) AR043579A1 (pl)
AT (1) ATE546459T1 (pl)
AU (1) AU2004224092B2 (pl)
BR (1) BRPI0408569B1 (pl)
CA (1) CA2519752C (pl)
CL (1) CL2004000636A1 (pl)
CY (1) CY1112970T1 (pl)
DK (1) DK1611150T3 (pl)
EA (1) EA011157B1 (pl)
ES (1) ES2382928T3 (pl)
HR (1) HRP20050917B1 (pl)
IL (1) IL170746A (pl)
MX (1) MXPA05010041A (pl)
MY (1) MY143936A (pl)
NO (1) NO331984B1 (pl)
NZ (1) NZ542827A (pl)
PE (1) PE20050388A1 (pl)
PL (1) PL1611150T3 (pl)
PT (1) PT1611150E (pl)
RS (1) RS52549B (pl)
SI (1) SI1611150T1 (pl)
TW (1) TWI328589B (pl)
WO (1) WO2004085460A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
JP2009512733A (ja) * 2005-11-02 2009-03-26 シコール インコーポレイティド シクレソニドの改良された製造法
WO2007092574A2 (en) * 2006-02-08 2007-08-16 Sicor, Inc. Crystalline forms of ciclesonide
WO2008015696A2 (en) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Process for preparing ciclesonide
WO2008062450A2 (en) * 2006-09-18 2008-05-29 Cadila Healthcare Limited Crystalline polymorphs of ciclesonide
CA2663737A1 (en) * 2006-09-19 2008-03-27 Cipla Limited Processes for the preparation of ciclesonide and its crystal form
JP2011513469A (ja) * 2008-03-13 2011-04-28 ファルマビオス ソシエタ ペル アチオニ プレグナン誘導体の製造法
IT1397499B1 (it) * 2009-01-09 2013-01-16 Farmabios Spa Processo per la preparazione di ciclesonide
WO2010054158A2 (en) * 2008-11-07 2010-05-14 Auspex Pharmaceuticals, Inc. Steroid modulators of glucocorticoid receptor
US9109005B2 (en) 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
WO2014007770A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising corticosteroid and sorbitol
WO2014007781A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions
US10111957B2 (en) 2012-07-05 2018-10-30 Arven Ilac Snayi ve Ticaret A.S. Inhalation compositions comprising glucose anhydrous
US20180126000A1 (en) 2016-06-02 2018-05-10 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof
BR112020010694A2 (pt) 2017-12-01 2020-11-10 Abbvie Inc. agonista de receptor de glicocorticoides e imunoconjugados do mesmo

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328929D0 (en) 1983-10-29 1983-11-30 Sterwin Ag Steroid compounds
AU624421B2 (en) 1988-10-05 1992-06-11 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
ATE111364T1 (de) 1989-05-31 1994-09-15 Fisons Plc Medikament und inhalationsvorrichtung dafür.
GR1001529B (el) 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
FR2668945B1 (fr) 1990-11-12 1993-02-19 Theramex Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus.
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
DK0701565T3 (da) 1993-04-02 1999-07-12 Byk Gulden Lomberg Chem Fab Nye prednisolonderivater
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of medicament formulations
ATE198074T1 (de) 1994-03-09 2000-12-15 Byk Gulden Lomberg Chem Fab Neue silylverbindungen und ihre verwendung
DE19541689A1 (de) 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
DE19635498A1 (de) * 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
US6120752A (en) 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
GB9722285D0 (en) 1997-10-23 1997-12-17 Rhone Poulenc Rorer Ltd Inhalation device
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
ES2234266T3 (es) * 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
GB9828721D0 (en) 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
JP2003516115A (ja) * 1999-06-25 2003-05-13 コグニス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ナノスケールステロールおよびステロールエステルの使用
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
ES2351184T3 (es) 2000-11-10 2011-02-01 Nycomed Gmbh Procedimiento para la producción de 16,17-[(ciclohexilmetilen)bis(oxil)]-11,21-dihidroxi-pregna-1,4-dien-3,20-diona o su 21-isobutirato mediante transcetalización.

Also Published As

Publication number Publication date
HK1088905A1 (zh) 2006-11-17
BRPI0408569A (pt) 2006-03-21
IL170746A (en) 2012-06-28
CL2004000636A1 (es) 2005-02-04
US9422327B2 (en) 2016-08-23
DK1611150T3 (da) 2012-05-14
CA2519752A1 (en) 2004-10-07
IL170746A0 (en) 2009-02-11
SI1611150T1 (sl) 2012-06-29
NZ542827A (en) 2008-02-29
ES2382928T3 (es) 2012-06-14
NO20054835L (no) 2005-10-19
EA011157B1 (ru) 2009-02-27
AR043579A1 (es) 2005-08-03
RS52549B (sr) 2013-04-30
JP2006521332A (ja) 2006-09-21
AU2004224092A1 (en) 2004-10-07
KR101102709B1 (ko) 2012-01-05
EP1611150B1 (en) 2012-02-22
EP1611150A1 (en) 2006-01-04
AU2004224092B2 (en) 2010-03-04
HRP20050917B1 (hr) 2014-02-14
PE20050388A1 (es) 2005-05-30
CY1112970T1 (el) 2016-04-13
WO2004085460A1 (en) 2004-10-07
MXPA05010041A (es) 2005-11-17
ATE546459T1 (de) 2012-03-15
PT1611150E (pt) 2012-05-07
US20060128954A1 (en) 2006-06-15
EA200501391A1 (ru) 2006-06-30
KR20050114250A (ko) 2005-12-05
WO2004085460A8 (en) 2007-03-15
RS20050704A (sr) 2007-06-04
CA2519752C (en) 2012-05-29
HRP20050917A2 (en) 2006-12-31
TWI328589B (en) 2010-08-11
TW200418519A (en) 2004-10-01
JP4746535B2 (ja) 2011-08-10
BRPI0408569B1 (pt) 2017-08-29
NO331984B1 (no) 2012-05-21
MY143936A (en) 2011-07-29

Similar Documents

Publication Publication Date Title
ZA200506900B (en) Method for preparing small particles
IL175363A0 (en) Urea derivative and process for preparing the same
IL172331A0 (en) Processes for preparing 3-benzazepines
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
IL172766A0 (en) Process for making thermoplastic vulcanizates
IL186260A0 (en) Alunite compound particle, process for producing the same and use thereof
SI1611150T1 (sl) Postopek za pripravo kristaliničnega ciklezonida z definirano velikostjo delcev
IL169879A0 (en) Process for preparing pyrrolotriazine derivatives
SG137677A1 (en) Improved process for preparing polyalkenylsuccinimides
EG23557A (en) Process for preparing aripiprazole
IL183239A0 (en) Process for preparing amorphous valsartan
AU2002345829A1 (en) Process for preparing g-csf
IL172444A0 (en) Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative
EP1612213A4 (en) PROCESS FOR PREPARING 2-DESOXY-2-FLUORURIDINE
EP1719776A4 (en) SILICON COMPOUND AND PROCESS FOR PRODUCING THE SAME
AU2003304458A1 (en) Nickel powder and process for producing the same
TWI347945B (en) Process for the preparation of thiazolopyrimidines
IL175216A0 (en) Process for preparing methyllithium
GB2404560B (en) Process for preparing a milk powder
AU2003248987A8 (en) Process for preparing 7-azaindoles
ZA200802814B (en) Thiomorpholine compound and process for preparing the same
AU2003240491A8 (en) Process for preparing vinylaromatic compounds
PL1698619T3 (pl) Sposób wytwarzania pochodnej 2-halogenobenzamidu
EP1623969A4 (en) ALPHA-PENTAFLUOROETHYLACRYLIC ACID DERIVATIVE AND PROCESS FOR PREPARING THE SAME
GB2412373B (en) Process for preparing guggulsterones